Updated:
Seagen
Seagen is a Chinese company founded in 2007. It specializes in logistics solutions utilizing advanced UAVs and intelligent warehouse management systems.
Seagen
Seagen is a Chinese company founded in 2007. It specializes in logistics solutions utilizing advanced UAVs and intelligent warehouse management systems. The company has secured 16.6 million US dollars in total funding.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Bothell
Corporate office
Bothell, WA, United States
Additional offices
Cambridge · New York · Rockville · Hellerup · Hoboken · Montreal
Sector focus
Frequently asked questions
Who founded Seagen?
Seagen was founded in 1997 by Clay Siegall, a scientist who pioneered the antibody-drug conjugate (ADC) platform. Siegall served as CEO until the acquisition by Pfizer (per the company's SEC filings).
What drugs did Seagen develop?
Seagen developed Adcetris (brentuximab vedotin) for lymphoma, approved in 2011, and Padcev (enfortumab vedotin) for bladder cancer, co-developed with Astellas. The company also had a pipeline of early-stage ADC candidates for solid tumors and hematologic malignancies.
How did Seagen make money?
Seagen earned revenue from sales of its approved drugs and from royalties on licensed technology. It had partnerships with Takeda (for Adcetris in certain territories) and Astellas (for Padcev), among others.
Is Seagen still an independent company?
No. Pfizer completed its acquisition of Seagen in December 2023 for $43B. Seagen now operates as part of Pfizer's Oncology division (per Pfizer, December 2023).
What was Seagen's headquarters?
Seagen was headquartered in Bothell, Washington, and had additional offices in New York, Rockville, Cambridge (MA), Hoboken, Montreal, and Hellerup, Denmark.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: